Microbially mediated phenolic catabolites exert differential genoprotective activities in normal and adenocarcinoma

Brian Óg Murphy1, Cheryl Latimer1, Sara Dobani1

  • 1Nutrition Innovation Centre for Food and Health (NICHE), Ulster University, Coleraine, UK.

Insights

Phenolic metabolites from gut microbes can protect colon cells from DNA damage. These compounds activate the Nrf2-ARE pathway, offering a potential strategy to reduce cancer risk associated with aging.

Area of Science:

  • Cellular and Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Aging is linked to decreased Nrf2 activity and DNA repair, increasing cancer risk.
  • Accumulated DNA damage is a key factor in age-related cancer development.
  • (Poly)phenols and their microbial metabolites show potential for DNA damage reduction.

Purpose of the Study:

  • To investigate the genoprotective effects of four colonic-microbiota-derived phenolic catabolites.
  • To determine the impact of these metabolites on the Nrf2-Antioxidant Response Element (ARE) pathway.
  • To assess their efficacy in normal and cancerous colonocyte cell lines.

Main Methods:

  • Utilized normal (CCD 841 CoN) and adenocarcinoma (HT29) colonocyte cell lines.
  • Exposed cells to hydrogen peroxide (H2O2) to induce oxidative DNA damage.
  • Assessed the ability of phenolic catabolites to reduce DNA damage and modulate Nrf2-ARE pathway genes.

Main Results:

  • All four phenolic catabolites exhibited significant genoprotective activity (p < .001).
  • The metabolites effectively modulated key genes within the Nrf2-ARE pathway.
  • Reduced DNA damage was observed in both normal and adenocarcinoma cells at physiologically relevant concentrations.

Conclusions:

  • Colon-derived phenolic metabolites demonstrate significant genoprotective effects against oxidative DNA damage.
  • These metabolites upregulate the Nrf2-ARE pathway, contributing to their protective function.
  • This suggests a potential therapeutic strategy for mitigating age-related DNA damage and cancer risk.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K